Efficacy of dapagliflozin in spectrum of chronic kidney disease

A study conducted in a rural tertiary care hospital in Central India aiming to investigate Efficacy of dapagliflozinin spectrum of chronic kidney disease . The rationale behind the study is to assess the trend of eGFR / serum creatinine and proteinuria over a period of six months after starting dapagliflozin& to look for Side effects in period of six months after starting medication and potentially improving patient outcomes. The study design is a cross-sectional study with a duration of 24 months, conducted at Acharya Vinoba Bhave Rural Hospital. The sample size is determined to be 112 patients meeting specific inclusion criteria. Data collection involves obtaining baseline demographic and clinical data, including age, gender, BMI, and blood pressure, and analyzing serum samples for various biochemical markers. Ethical considerations, including patient confidentiality and informed consent, are emphasized. The primary outcome is the to assess the trend of eGFR / serum creatinine and proteinuria over a period of six months after starting dapagliflozin. The abstract highlights the study’s potential contributions to CKD management in the rural Indian population.